News

Oncopeptalks: Q1 report

Redeye interviews Oncopeptides CEO Sofia Heigis

Launching: Oncopeptalks as a podcast

CEO Sofia Heigis presented at Redeye event Commercialization in Life Science

Sofia Heigis presented and interviewed at Stockholm Corporate Finance Life Science Days

Oncopeptides initiates MARINA study to strengthen real-world evidence for Pepaxti in Germany

European Journal of Haematology: Real-World Data reinforces Pepaxti’s role in treatment sequencing for multiple myeloma

CEO Sofia Heigis presents Oncopeptides at Aktiespararna

Oncopeptides secures fast-track designation for Window-of-Opportunity study in glioblastoma

Biostock: presentation and interview with Sofia Heigis

Oncopeptides CEO Sofia Heigis interviewed by Redeye about Q4 and the new share issue

CEO Sofia Heigis interviewed by Redeye